Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P10415 (
Bcl-2
)
33,771
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The mitochondria-mediated apoptotic pathway is regulated by members of the
Bcl-2
family. Epidermal growth factor (EGF) induces Bad phosphorylation at Ser112 via mitogen-activated protein kinase (MAPK), impairing its binding to
Bcl-2
and Bcl-xL and interfering with their anti-apoptotic functions. In the current study, we utilized Western blot, immunofluorescence, flow cytometry, and confocal microscopy to examine the effects of
CMTM8
overexpression on apoptosis. Our data indicated levels of Bad-S112 phosphorylation were lower in
CMTM8
-transfected cells compared to pCDB-transfected cells. Caspase-dependent and independent mediated apoptosis, induced by
CMTM8
overexpression, was facilitated by the mitochondria and inhibited by knockdown of Bad or overexpression of Bcl-xL. Previous research in our laboratory also demonstrated
CMTM8
attenuated EGFR-mediated signaling pathways by decreasing ERK1/2 phosphorylation levels. These data implicate
CMTM8
as a negative regulator of EGF-induced signaling, with potential use as a novel therapeutic gene for EGFR-targeted anticancer gene therapy.
...
PMID:CMTM8 induces caspase-dependent and -independent apoptosis through a mitochondria-mediated pathway. 1714 3